The major signalling pathway involved in both HPV+ and HPV− oropharyngeal cancers appears to be the PI3K-AKT-mTOR (PI3K) pathway, as opposed to the NF-B pathway seen in EBV+ NPC. Here, PIK3CA is linked to oropharynx cancer.